Reply to Itagaki et al. Comment on "Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416"

Karolina Dorobisz,Tadeusz Dorobisz,Katarzyna Pazdro-Zastawny
DOI: https://doi.org/10.3390/cancers16233952
2024-11-28
Cancers
Abstract:Cancers, Vol. 16, Pages 3952: Reply to Itagaki et al. Comment on “Dorobisz et al. Assessment of Prognostic Factors, Clinical Features Including the Microbiome, and Treatment Outcomes in Patients with Cancer of Unknown Primary Site. Cancers 2024, 16, 3416” Cancers doi: 10.3390/cancers16233952 Authors: Karolina Dorobisz Tadeusz Dorobisz Katarzyna Pazdro-Zastawny In his commentary [...]
oncology
What problem does this paper attempt to address?